Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
Hypogonadism in male patients is defined as a decrease in the serum testosterone level; it is associated with specific symptoms and/or signs (see the detailed description below). It is a common complication in diabetes mellitus. The guidelines do not review all disorders leading to the development o...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2017-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/8728 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849327427827793920 |
|---|---|
| author | Galina Afanas'evna Melnichenko Marina Vladimirovna Shestakova Roman Viktorovich Rozhivanov Anna Leont'evna Terehova Alexey Vadimovich Zilov Daria Olegovna Ladygina Dmitriy Gennad'evich Kurbatov |
| author_facet | Galina Afanas'evna Melnichenko Marina Vladimirovna Shestakova Roman Viktorovich Rozhivanov Anna Leont'evna Terehova Alexey Vadimovich Zilov Daria Olegovna Ladygina Dmitriy Gennad'evich Kurbatov |
| author_sort | Galina Afanas'evna Melnichenko |
| collection | DOAJ |
| description | Hypogonadism in male patients is defined as a decrease in the serum testosterone level; it is associated with specific symptoms and/or signs (see the detailed description below). It is a common complication in diabetes mellitus. The guidelines do not review all disorders leading to the development of hypogonadism but focus on options for the treatment of hypogonadism, which is generally observed in male patients with diabetes. In the literature, data on the prevalence of hypogonadism in patients with diabetes are available. In the section on diagnostics, the medical history of patients with hypogonadism and diabetes, including the necessary methods for physical and laboratory inspection. Risk factors for and the clinical consequences of hypogonadism are separately considered. In the section on treatment options, variations in treatment using various androgenic therapeutic agents based on patients’ requirements, conservation of their reproductive function, and their risk factors are provided. Special attention is given to indications of, contraindications of and risk factors for androgenic therapy in male patients with diabetes, particularly those in their advanced age. The principles of the clinical monitoring are developed. The favourable effects of androgenic therapy for hypogonadism in male patients with diabetes are shown. |
| format | Article |
| id | doaj-art-cf3ac0a7bdd644319a11f6bc4192c09d |
| institution | Kabale University |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2017-06-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-cf3ac0a7bdd644319a11f6bc4192c09d2025-08-20T03:47:53ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782017-06-0120215116010.14341/78847844Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)Galina Afanas'evna Melnichenko0Marina Vladimirovna Shestakova1Roman Viktorovich Rozhivanov2Anna Leont'evna Terehova3Alexey Vadimovich Zilov4Daria Olegovna Ladygina5Dmitriy Gennad'evich Kurbatov6<p>Endocrinology Research Centre, Moscow; I.M.Sechenov First Moscow State Medical University</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>I.M.Sechenov First Moscow State Medical University</p><p>I.M.Sechenov First Moscow State Medical University</p><p>Central Clinical Hospital of the Management Affair of President Russian Federation</p><p>Endocrinology Research Centre</p>Hypogonadism in male patients is defined as a decrease in the serum testosterone level; it is associated with specific symptoms and/or signs (see the detailed description below). It is a common complication in diabetes mellitus. The guidelines do not review all disorders leading to the development of hypogonadism but focus on options for the treatment of hypogonadism, which is generally observed in male patients with diabetes. In the literature, data on the prevalence of hypogonadism in patients with diabetes are available. In the section on diagnostics, the medical history of patients with hypogonadism and diabetes, including the necessary methods for physical and laboratory inspection. Risk factors for and the clinical consequences of hypogonadism are separately considered. In the section on treatment options, variations in treatment using various androgenic therapeutic agents based on patients’ requirements, conservation of their reproductive function, and their risk factors are provided. Special attention is given to indications of, contraindications of and risk factors for androgenic therapy in male patients with diabetes, particularly those in their advanced age. The principles of the clinical monitoring are developed. The favourable effects of androgenic therapy for hypogonadism in male patients with diabetes are shown.https://www.dia-endojournals.ru/jour/article/view/8728hypogonadismmale patientstestosterone deficiencytestosteronediabetes mellitusmetabolic syndrome |
| spellingShingle | Galina Afanas'evna Melnichenko Marina Vladimirovna Shestakova Roman Viktorovich Rozhivanov Anna Leont'evna Terehova Alexey Vadimovich Zilov Daria Olegovna Ladygina Dmitriy Gennad'evich Kurbatov Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft) Сахарный диабет hypogonadism male patients testosterone deficiency testosterone diabetes mellitus metabolic syndrome |
| title | Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft) |
| title_full | Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft) |
| title_fullStr | Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft) |
| title_full_unstemmed | Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft) |
| title_short | Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft) |
| title_sort | guidelines for the diagnosis and treatment of testosterone deficiency hypogonadism in male patients with diabetes mellitus draft |
| topic | hypogonadism male patients testosterone deficiency testosterone diabetes mellitus metabolic syndrome |
| url | https://www.dia-endojournals.ru/jour/article/view/8728 |
| work_keys_str_mv | AT galinaafanasevnamelnichenko guidelinesforthediagnosisandtreatmentoftestosteronedeficiencyhypogonadisminmalepatientswithdiabetesmellitusdraft AT marinavladimirovnashestakova guidelinesforthediagnosisandtreatmentoftestosteronedeficiencyhypogonadisminmalepatientswithdiabetesmellitusdraft AT romanviktorovichrozhivanov guidelinesforthediagnosisandtreatmentoftestosteronedeficiencyhypogonadisminmalepatientswithdiabetesmellitusdraft AT annaleontevnaterehova guidelinesforthediagnosisandtreatmentoftestosteronedeficiencyhypogonadisminmalepatientswithdiabetesmellitusdraft AT alexeyvadimovichzilov guidelinesforthediagnosisandtreatmentoftestosteronedeficiencyhypogonadisminmalepatientswithdiabetesmellitusdraft AT dariaolegovnaladygina guidelinesforthediagnosisandtreatmentoftestosteronedeficiencyhypogonadisminmalepatientswithdiabetesmellitusdraft AT dmitriygennadevichkurbatov guidelinesforthediagnosisandtreatmentoftestosteronedeficiencyhypogonadisminmalepatientswithdiabetesmellitusdraft |